Answers are grounded in this paper and cite their sources.
Gangliosides, including GM1 ganglioside (GM1), are sialic acid-containing glycosphingolipids that are involved in essential physiological roles such as cell–cell recognition, adhesion, transmembrane signaling, neuronal development, and cell fate determination. They are crucial to all phases of neuronal development. Gangliosides are enriched in the outer layer of neuronal membranes of the nervous system, where their contents are ten times higher than in other cell types. Moreover, gangliosides (especially GM1) have neuroprotective effects on neuronal cells through various pathways, although the identities of these pathways remain relatively unclear. Notably, some neurodegenerative diseases, such as Parkinson’s disease, have recently been reported to be associated with significant deficiencies of some gangliosides. Because of their location on the outer layer of the plasma membrane of neurons and immune cells, some anti-ganglioside antibodies can attack and bind to these cell-surface gangliosides. These antibodies provoke unexpected and unfavorable effects in neuronal and immune cells, as observed in Guillain–Barré syndrome with anti-GM1 antibodies. At present, however, the molecular mechanisms of these unfavorable effects remain to be explored. Here, I describe the molecular actions of gangliosides in the nervous system as both neuroprotective and neurotoxic agents.
No takes yet. Share an insight, caveat, or question.
Tatsuro Mutoh (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: